Yes, they would get upfront money, no milestones. Milestones are usually associated with licensing to other companies.
I'm not saying there is a partnership, but with officers buying, it seems to be a possibility. imo, a partnership wouldn't get the price above $1.
Some news/results of a clinical trial, commence a Phase 3 clinical trial could move the price higher.
A combination of these also.
I'd like to know what is about to occur, but I can only speculate. Any of the things I have listed in my latest msgs are only speculations and I'm not convince that any or all will occur.
Buying by the officers has really changed the how I/we view this situation. Topsy turvy.
Wennekamp Richard L. too.
For the first time in many years, they are buying on the open market after a delist letter and before the Nasdaq panel's decision.
It doesn't make sense to me that they would buy before a reverse split. So, maybe there is something else occurring that is more favorable to/by Nasdaq as to the reason they are buying now.
I hope you are right ijob. Four points to consider.
1. I don't recall any DIRECTOR EVER buying on the open market in over NINE YEARS.
2. NASDAQ is holding his feet to the fire over delisting and the CEO is compelled to do something about it.
3. Earnings are due March 5th [if he is not late]
4. Technical Analysis does show an upward trend and if it holds above 35 today [looking more and more likely] the next real Resistance is .45c
On the whole looking more positive. Would you agree?
WTF! Kriegsmann buying shares on the open market? This is too much! Well he has tried every other scam in the book, he might as well try this one to snag a few more victims before Earnings n March 5th! All imo of course! LOL!
Not only CEO bought (158.000 shares), also GC/VP Levin Ben bought at the open market (some 34.000 shares)